San Martin Javier bought ATHA

December 31, 2025 · Form 4 insider transaction

San Martin Javier bought 4,667 shares of Athira Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
4,667
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after11,833
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reported number of shares in this Form 4 has been adjusted to reflect the impact of the Issuer's 10-for-1 reverse stock split completed on September 17, 2025 (the "Reverse Stock Split").

View the original Form 4 on SEC EDGAR